↑Scognamiglio B, Baldassarre G, Cassano C, Tucci M, Montuori N, Dono R, Lembo G, Barra A, Lago CT, Viglietto G, Rocchi M, Persico MG (Jul 1999). "Assignment of human teratocarcinoma derived growth factor (TDGF) sequences to chromosomes 2q37, 3q22, 6p25 and 19q13.1". Cytogenet Cell Genet. 84 (3–4): 220–4. doi:10.1159/000015263. PMID10393436.
Saccone S, Rapisarda A, Motta S, et al. (1995). "Regional localization of the human EGF-like growth factor CRIPTO gene (TDGF-1) to chromosome 3p21". Hum. Genet. 95 (2): 229–30. doi:10.1007/BF00209409. PMID7860072.
Brandt R, Normanno N, Gullick WJ, et al. (1994). "Identification and biological characterization of an epidermal growth factor-related protein: cripto-1". J. Biol. Chem. 269 (25): 17320–8. PMID8006041.
Friess H, Yamanaka Y, Büchler M, et al. (1994). "Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis". Int. J. Cancer. 56 (5): 668–74. doi:10.1002/ijc.2910560511. PMID8314343.
Panico L, D'Antonio A, Salvatore G, et al. (1996). "Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues". Int. J. Cancer. 65 (1): 51–6. doi:10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0. PMID8543395.
Kannan S, De Santis M, Lohmeyer M, et al. (1997). "Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells". J. Biol. Chem. 272 (6): 3330–5. doi:10.1074/jbc.272.6.3330. PMID9013573.
Xu C, Liguori G, Persico MG, Adamson ED (1999). "Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes". Development. 126 (3): 483–94. PMID9876177.
Ebert AD, Wechselberger C, Frank S, et al. (1999). "Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells". Cancer Res. 59 (18): 4502–5. PMID10493495.
de la Cruz JM, Bamford RN, Burdine RD, et al. (2002). "A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects". Hum. Genet. 110 (5): 422–8. doi:10.1007/s00439-002-0709-3. PMID12073012.